BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12635092)

  • 1. Targeting lethal minimal residual disease in small cell lung cancer.
    Patel JD; Krug LM; Azzoli CG; Gomez J; Kris MG; Miller VA
    Semin Oncol; 2003 Feb; 30(1):79-85. PubMed ID: 12635092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
    Krug LM; Grant SC; Miller VA; Ng KK; Kris MG
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):55-61. PubMed ID: 10566613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer.
    Shepherd FA
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):30-7. PubMed ID: 11479895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for relapsed small-cell lung cancer.
    Azim HA; Ganti AK
    Anticancer Drugs; 2007 Mar; 18(3):255-61. PubMed ID: 17264756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in management of small-cell lung cancer.
    Chua YJ; Steer C; Yip D
    Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of novel treatment strategies.
    Giaccone G
    Oncogene; 2002 Oct; 21(45):6970-81. PubMed ID: 12362278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy].
    Brückl WM; Lampert S; Zirlik S; Hahn EG; Wiest GH
    Pneumologie; 2008 Jan; 62(1):23-30. PubMed ID: 17948174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for lung cancer: the state of the art in 2009.
    Higgins MJ; Ettinger DS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small cell lung cancer: state of the art and future perspectives.
    Stupp R; Monnerat C; Turrisi AT; Perry MC; Leyvraz S
    Lung Cancer; 2004 Jul; 45(1):105-17. PubMed ID: 15196740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New molecular targets and biological therapies in sarcomas.
    Scappaticci FA; Marina N
    Cancer Treat Rev; 2001 Dec; 27(6):317-26. PubMed ID: 11908925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M; Kollmeier J
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer.
    Ettinger DS
    Oncologist; 2006 Apr; 11(4):358-73. PubMed ID: 16614231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New targeted therapies and small-cell lung cancer.
    Rossi A; Maione P; Palazzolo G; Sacco PC; Ferrara ML; Falanga M; Gridelli C
    Clin Lung Cancer; 2008 Sep; 9(5):271-9. PubMed ID: 18824449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of radiotherapy in the management of patients with small cell lung cancer].
    Daveau C; Le Péchoux C; Besse B; Ferreira I; Amarouch A; Vicenzi L; Elloumi F; Roberti E; Bretel JJ
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S171-9. PubMed ID: 18235411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of new targeted therapies in small-cell lung cancer.
    Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
    Maas KW; El Sharouni SY; Smit EF; Schramel FM
    Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.
    Antonia SJ; Mirza N; Fricke I; Chiappori A; Thompson P; Williams N; Bepler G; Simon G; Janssen W; Lee JH; Menander K; Chada S; Gabrilovich DI
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):878-87. PubMed ID: 16467102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small cell lung cancer and targeted therapies.
    Blackhall FH; Shepherd FA
    Curr Opin Oncol; 2007 Mar; 19(2):103-8. PubMed ID: 17272981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of small cell lung cancer.
    Yip D; Karapetis C; Steer C
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):197-210. PubMed ID: 12113025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.